Cite
Random aneuploidy in CML patients at diagnosis and under imatinib treatment
MLA
Moshe Fejgin, et al. “Random Aneuploidy in CML Patients at Diagnosis and under Imatinib Treatment.” Cancer Genetics and Cytogenetics, vol. 168, no. 2, Dec. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ccef93fcd6aadc6448dca15d7b34409&authtype=sso&custid=ns315887.
APA
Moshe Fejgin, E. Gaber, L. Leopold, Michael Lishner, A. Amiel, M. Yukla, & G. Josef. (2005). Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genetics and Cytogenetics, 168(2).
Chicago
Moshe Fejgin, E. Gaber, L. Leopold, Michael Lishner, A. Amiel, M. Yukla, and G. Josef. 2005. “Random Aneuploidy in CML Patients at Diagnosis and under Imatinib Treatment.” Cancer Genetics and Cytogenetics 168 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ccef93fcd6aadc6448dca15d7b34409&authtype=sso&custid=ns315887.